-
Mashup Score: 0VJOncology – The video journal of oncology - 8 month(s) ago
The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the awareness and understanding of oncology
Source: www.vjoncology.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Dr Garon continues with an explanation of the updated analysis of the POSEIDON trial presented at the 2022 World Conference on Lung Cancer.
Source: Targeted OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Garon, MD, MS continues with an explanation of the updated analysis of the POSEIDON trial presented at the 2022 World Conference on Lung Cancer. #wclc22 #lcsm #nsclc | @dgsomucla https://t.co/p7uikTNS0r
-
-
Mashup Score: 0
Dr Millie Das, MD opens a discussion surrounding updates regarding non-small cell lung cancer (NSCLC) as presented at the 2022 World Conference on Lung Cancer (WCLC).
Source: AJMCCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
In our Post Conference Perspectives series for #WCLC22, Dr Millie Das (@DasMillie11) opens a discussion surrounding updates regarding #NSCLC, including results of the #IMpower010 trial evaluating #atezolizumab vs best supportive care. https://t.co/PvxrhFWNO7 @IASLC https://t.co/yVZuOm5x2R
-
-
Mashup Score: 0
Dr Garon continues with an explanation of the updated analysis of the POSEIDON trial presented at the 2022 World Conference on Lung Cancer.
Source: Targeted OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Garon, MD, MS continues with an explanation of the updated analysis of the POSEIDON trial presented at the 2022 World Conference on Lung Cancer. #wclc22 #lcsm #nsclc | @dgsomucla https://t.co/p7uikTOpPZ
-
-
Mashup Score: 1ES14 - Think,+Think,+Think_..The+Importance+of+Thinking+Holistically+When+Caring+for+Lung+Cancer+Patients - 1 year(s) ago
This is “ES14 – Think,+Think,+Think_..The+Importance+of+Thinking+Holistically+When+Caring+for+Lung+Cancer+Patients” by Grit Schoenherr on Vimeo, the home…
Source: VimeoCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
During #WCLC22 the @IASLC Nursing & Allied Health Committee highlighted the need to think & act holistically/individually when caring for patients with #lungcancer. Learn more from @LornaMcW, Simon Dunne, @ONPNZ, @ElenaSchiena & Marianne Davies. https://t.co/SVsDtRySKI #LCAM22 https://t.co/1HH8AtvVtH
-
-
Mashup Score: 2OA13 - Evolving+Epidemiology+of+Lung+Cancer+Beyond+Tobacco - 1 year(s) ago
This is “OA13 – Evolving+Epidemiology+of+Lung+Cancer+Beyond+Tobacco” by Grit Schoenherr on Vimeo, the home for high quality videos and the people who love…
Source: VimeoCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
During #LCAM22, @IASLC shares the Evolving Epidemiology of #Lungcancer Beyond Tobacco presented during #WCLC22. This engaging 1-hour global session highlights air pollution, radon, asbestos, risk prediction in never-smokers, & more. Watch now: https://t.co/e6kjJRR2iI #LCSA https://t.co/aPYJ2GYviK
-
-
Mashup Score: 0POSEIDON Analysis Shows Sustained Benefit with Triplet Regimen Regardless of Mutational Status - ILCN.org (ILCN/WCLC) - 2 year(s) ago
Dr. Solange Peters showed 24-month overall survival rates were higher with tremelimumab, durvalumab, and chemotherapy versus chemotherapy alone across all subgroups, including those with KRAS, STK11, and KEAP1 mutations.
Source: ILCN.org (ILCN/WCLC)Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
At #WCLC22, @peters_solange showed 24-month OS was higher with tremelimumab, durvalumab, and chemo vs. chemo alone across all subgroups. Read a recap in ILCN: https://t.co/MZV5ldUXKS #LCSM
-
-
Mashup Score: 0Study Shows Shorter-Term Assessments Underestimate Pollution Exposure - ILCN.org (ILCN/WCLC) - 2 year(s) ago
During WCLC 22, Dr. Renelle Myers demonstrated the importance of considering long-term cumulative exposure to air pollutants when assessing individual lung cancer risk.
Source: ILCN.org (ILCN/WCLC)Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
During #WCLC22, @MyersRenelle discussed the consideration of long-term exposure to air pollutants when assessing individual lung cancer risk. Read a recap in ILCN: https://t.co/VK8yRPtZS8 #LCSM
-
-
Mashup Score: 0KEYNOTE-604 Follow-Up Results Continue to Show Clinically Meaningful Improvement - ILCN.org (ILCN/WCLC) - 2 year(s) ago
Long-term data presented by Dr. Charles Rudin during WCLC 2022 showed significant OS benefit for patients with extensive stage SCLC on pembrolizumab combination versus placebo.
Source: ILCN.org (ILCN/WCLC)Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Long-term data presented by @charlesrudin at #WCLC22 showed significant OS benefit for extensive stage SCLC with pembro combo vs. placebo. Read more in ILCN: https://t.co/M9leDJKz6A #LCSM
-
-
Mashup Score: 2Sublobar Resection for Small, Early-Stage NSCLC: Establishing a New Standard of Care? - The ASCO Post - 2 year(s) ago
After a nearly 20-year wait, the results are finally in: sublobar surgery has been found to be noninferior to lobectomy and may be the new standard of care of patients with small, early-stage non–small cell lung cancer (NSCLC). Results of the phase III Alliance trial, presented at the International Association for the Study of Lung Cancer (IASLC) 2022 World Conference on Lung Cancer, showed a…
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Sublobar Resection for Small, Early-Stage NSCLC: Establishing a New Standard of Care? https://t.co/Jh0TdhJgRc #WCLC22 #WCLC2022 #LCSM #lungcancer #oncology
-
Interested in seeing why we’re so excited for #WCLC23? 🌍🫁 Visit https://t.co/qH0bG8agF6 to see last year’s coverage at #WCLC22 to get you ready and raring to go this time round! @IASLC #LungCancer #LCsm #NSCLC #SCLC https://t.co/gYWTotiByD